TESSCO Technologies Incorporated Receives Stockholder Approval to Merge and Announces Expected Merger Closing Date

Stock Information for TCR2 Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TCR2 Therapeutics Inc.

TESSCO Announces Closing of Merger Transaction
IMPORTANT ALERT: Halper Sadeh LLC Investigates AMED, SYNH, CHRA, TESS
IMPORTANT ALERT: Halper Sadeh LLC Investigates AMED, ASRT, SYNH, TESS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates QUOT, PRTK, TESS, HMPT
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eneti Inc. (NYSE - NETI), Franchise Group, Inc. (Nasdaq - FRG), Tessco Technologies Incorporated (Nasdaq - TESS), NexTier Oilfield Solutions Inc. (NYSE - NEX)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, TESS, FRG, GRNA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SYNH, DM, TESS, ISEE
TESSCO TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TESSCO Technologies Incorporated - TESS

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.